RxDoctor Payments Data

Frank Eismont, MD

Orthopaedic Surgery of the Spine · Miami, FLNPI 1720042310

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $116,234 of the $116,714 with a category attached, or 99.6%. Alphatec Spine, Inc accounts for 99.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $45,080 and has fallen 97.1% since, to $1,305 in 2025.

$116,714in general payments, 2019–2025

Across 58 payments — averaging $2012.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$116K
  • Stryker$173
  • Medtronic$156
  • Innovation Technologies Inc$151

What the payments were for

  • Royalty or licence$116,234100%
  • Food & beverage$4790%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alphatec Spine, Inc53$116,234
Stryker3$173
Medtronic1$156
Innovation Technologies Inc1$151

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$116,714 in reported general payments places this provider in the 70th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$18,502
Medicare patients
132
Services billed
173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib57$1,313
Calcitonin-SalmonCalcitonin,salmon,synthetic12$550
Gabapentin34$431
Methylprednisolone27$170
Meloxicam14$46

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →